Membrane protein production and formulation for drug discovery

E Gulezian, C Crivello, J Bednenko, C Zafra… - Trends in …, 2021 - cell.com
Integral membrane proteins (MPs) are important drug targets across most fields of medicine,
but historically have posed a major challenge for drug discovery due to difficulties in …

30 years of nanobodies–an ongoing success story of small binders in biological research

DI Frecot, T Froehlich… - Journal of Cell Science, 2023 - journals.biologists.com
ABSTRACT A milestone in the field of recombinant binding molecules was achieved 30
years ago with the discovery of single-domain antibodies from which antigen-binding …

Structure of the core human NADPH oxidase NOX2

S Noreng, N Ota, Y Sun, H Ho, M Johnson… - Nature …, 2022 - nature.com
NOX2 is the prototypical member of the NADPH oxidase NOX superfamily and produces
superoxide (O2•−), a key reactive oxygen species (ROS) that is essential in innate and …

SYNBIP: synthetic binding proteins for research, diagnosis and therapy

X Wang, F Li, W Qiu, B Xu, Y Li, X Lian… - Nucleic acids …, 2022 - academic.oup.com
The success of protein engineering and design has extensively expanded the protein space,
which presents a promising strategy for creating next-generation proteins of diverse …

An in silico method to assess antibody fragment polyreactivity

EP Harvey, JE Shin, MA Skiba, GR Nemeth… - Nature …, 2022 - nature.com
Antibodies are essential biological research tools and important therapeutic agents, but
some exhibit non-specific binding to off-target proteins and other biomolecules. Such …

Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brain

J Meng, C Xu, PA Lafon, S Roux, M Mathieu… - Nature chemical …, 2022 - nature.com
Membrane proteins, including ion channels, receptors and transporters, are often composed
of multiple subunits and can form large complexes. Their specific composition in native …

Structural basis of μ-opioid receptor targeting by a nanobody antagonist

J Yu, A Kumar, X Zhang, C Martin… - Nature …, 2024 - nature.com
The μ-opioid receptor (μOR), a prototypical G protein-coupled receptor (GPCR), is the target
of opioid analgesics such as morphine and fentanyl. Due to the severe side effects of current …

Synthetic nanobodies as tools to distinguish IgG Fc glycoforms

KS Kao, A Gupta, G Zong, C Li… - Proceedings of the …, 2022 - National Acad Sciences
Protein glycosylation is a crucial mediator of biological functions and is tightly regulated in
health and disease. However, interrogating complex protein glycoforms is challenging, as …

Emerging landscape of nanobodies and their neutralizing applications against SARS-CoV-2 virus

X Feng, H Wang - ACS Pharmacology & Translational Science, 2023 - ACS Publications
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the
coronavirus disease 2019 (COVID-19) has significantly altered people's way of life. Despite …

DEER analysis of GPCR conformational heterogeneity

M Elgeti, WL Hubbell - Biomolecules, 2021 - mdpi.com
G protein-coupled receptors (GPCRs) represent a large class of transmembrane helical
proteins which are involved in numerous physiological signaling pathways and therefore …